Table I.
Small airway epithelium | Alveolar macrophages | |||
---|---|---|---|---|
Parameter | Healthy nonsmokers |
Healthy smokers |
Healthy nonsmokers |
Healthy Smokers |
n | 35 | 35 | 22 | 34 |
Sex (male/female) | 28/7 | 22/13 | 17/5 | 24/10 |
Age (yr) | 43 ± 11 | 43 ± 6 | 41 ± 8 | 43 ± 7 |
Race (B/W/O)2 | 17/14/4 | 21/8/6 | 13/6/3 | 20/9/5 |
Smoking history (pack-yr) | 0 | 24 ± 13 | 0 | 26 ± 17 |
Urine nicotine (ng/ml) | 0 | 1029 ± 1045 | 0 | 796 ± 878 |
Urine cotinine (ng/ml) | 0 | 1158 ± 861 | 0 | 1060 ± 717 |
Blood carboxyhemoglobin (%) |
0.6 ± 0.9 | 2.2 ± 2.0 | 0.6 ± 0.8 | 2.4 ± 2.4 |
Pulmonary function parameters3 |
||||
FVC | 108 ± 12 | 109 ± 12 | 106 ± 11 | 109 ± 11 |
FEV1 | 108 ± 14 | 109 ± 13 | 106 ± 11 | 109 ± 12 |
FEV1/FVC | 82 ± 7 | 82 ± 4 | 82 ± 5 | 82 ± 4 |
TLC | 102 ± 13 | 101 ± 12 | 96 ± 8 | 99 ± 12 |
DLCO | 98 ± 15 | 97 ± 12 | 95 ± 9 | 98 ± 13 |
Epithelial cells | ||||
Number recovered | 6.0 × 106 | 6.1 × 106 | ||
% epithelial cells | 99.5 ± 0.9 | 99.7 ± 0.6 | ||
% inflammatory cells | 0.5 ± 0.9 | 0.3 ± 0.6 | ||
% ciliated | 74.4 ± 7.2 | 71.4 ± 7.4 | ||
% secretory | 7.0 ± 3.7 | 7.4 ± 3.1 | ||
% basal | 10.7 ± 4.7 | 10.1 ± 3.4 | ||
% undifferentiated | 7.3 ± 3.2 | 10.8 ± 5.7 | ||
BAL4 cells | ||||
Number recovered x106 | 14.1 ± 9.1 | 31.2 ± 20.3 | ||
% viability | 96.6 ± 1.2 | 96.3 ± 1.1 | ||
% alveolar macrophages5 | 96.0 ± 1.3 | 95.7 ± 1.7 | ||
% lymphocytes | 2.7 ± 1.6 | 2.8 ± 1.7 | ||
% polymorphonuclear cells | 0.9 ± 1.1 | 1.1 ± 1.3 | ||
% epithelial cells | 0.4 ± 0.7 | 0.4 ± 0.4 |
Data is presented as mean ± standard deviation.
B = black, W = white, O = other.
Pulmonary function testing parameters are given as percent of predicted value with the exception of FEV1/FVC, which is reported as % observed; FVC - forced vital capacity, FEV1 - forced expiratoryvolume in 1 sec, TLC - total lung capacity, DLCO - diffusing capacity of the lung for carbon monoxide.
Bronchoalveolar lavage.
Listed is the % AM before purification; after purification the AM were >98% pure.